0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Icatibant Acetate Injection Market Research Report 2026
Published Date: 2026-02-10
|
Report Code: QYRE-Auto-30Y18055
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Icatibant Acetate Injection Market Research Report 2024
BUY CHAPTERS

Global Icatibant Acetate Injection Market Research Report 2026

Code: QYRE-Auto-30Y18055
Report
2026-02-10
Pages:115
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Icatibant Acetate Injection Market

The global Icatibant Acetate Injection market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Icatibant Acetate Injection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Icatibant acetate injection is a synthetic bradykinin B2 receptor antagonist used to treat acute attacks of hereditary angioedema (HAE). Administered subcutaneously, icatibant provides rapid relief from symptoms like facial, throat, or abdominal swelling, and is a key treatment option for managing acute HAE attacks.
The North American market for Icatibant Acetate Injection is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Icatibant Acetate Injection is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Icatibant Acetate Injection include Takeda Pharmaceuticals, Eugia Pharma Specialities, Glenmark Pharmaceuticals, Sandoz, Cipla, Fresenius Kabi, Jiangsu Hengrui Pharmaceuticals, Chengdu Shengnuo Biology Pharmacy, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Icatibant Acetate Injection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Icatibant Acetate Injection. The Icatibant Acetate Injection market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Icatibant Acetate Injection market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Icatibant Acetate Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Icatibant Acetate Injection Market Report

Report Metric Details
Report Name Icatibant Acetate Injection Market
Segment by Type
  • Original Drug
  • Generic Drug
by Application
  • Hospital and Clinic
  • Pharmacy
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Takeda Pharmaceuticals, Eugia Pharma Specialities, Glenmark Pharmaceuticals, Sandoz, Cipla, Fresenius Kabi, Jiangsu Hengrui Pharmaceuticals, Chengdu Shengnuo Biology Pharmacy
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Icatibant Acetate Injection manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Icatibant Acetate Injection sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Icatibant Acetate Injection Market report?

Ans: The main players in the Icatibant Acetate Injection Market are Takeda Pharmaceuticals, Eugia Pharma Specialities, Glenmark Pharmaceuticals, Sandoz, Cipla, Fresenius Kabi, Jiangsu Hengrui Pharmaceuticals, Chengdu Shengnuo Biology Pharmacy

What are the Application segmentation covered in the Icatibant Acetate Injection Market report?

Ans: The Applications covered in the Icatibant Acetate Injection Market report are Hospital and Clinic, Pharmacy, Other

What are the Type segmentation covered in the Icatibant Acetate Injection Market report?

Ans: The Types covered in the Icatibant Acetate Injection Market report are Original Drug, Generic Drug

1 Icatibant Acetate Injection Market Overview
1.1 Product Definition
1.2 Icatibant Acetate Injection by Type
1.2.1 Global Icatibant Acetate Injection Market Value by Type: 2025 vs 2032
1.2.2 Original Drug
1.2.3 Generic Drug
1.3 Icatibant Acetate Injection by Application
1.3.1 Global Icatibant Acetate Injection Market Value by Application: 2025 vs 2032
1.3.2 Hospital and Clinic
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Icatibant Acetate Injection Market Size Estimates and Forecasts
1.4.1 Global Icatibant Acetate Injection Revenue 2021–2032
1.4.2 Global Icatibant Acetate Injection Sales 2021–2032
1.4.3 Global Icatibant Acetate Injection Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Icatibant Acetate Injection Market Competition by Manufacturers
2.1 Global Icatibant Acetate Injection Sales Market Share by Manufacturers (2021–2026)
2.2 Global Icatibant Acetate Injection Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Icatibant Acetate Injection Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Icatibant Acetate Injection, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Icatibant Acetate Injection, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Icatibant Acetate Injection, Product Types and Applications
2.7 Global Key Manufacturers of Icatibant Acetate Injection, Date of Entry into the Industry
2.8 Global Icatibant Acetate Injection Market Competitive Situation and Trends
2.8.1 Global Icatibant Acetate Injection Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Icatibant Acetate Injection Players Market Share by Revenue
2.8.3 Global Icatibant Acetate Injection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Icatibant Acetate Injection Market Scenario by Region
3.1 Global Icatibant Acetate Injection Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Icatibant Acetate Injection Sales by Region: 2021–2032
3.2.1 Global Icatibant Acetate Injection Sales by Region: 2021–2026
3.2.2 Global Icatibant Acetate Injection Sales by Region: 2027–2032
3.3 Global Icatibant Acetate Injection Revenue by Region: 2021–2032
3.3.1 Global Icatibant Acetate Injection Revenue by Region: 2021–2026
3.3.2 Global Icatibant Acetate Injection Revenue by Region: 2027–2032
3.4 North America Icatibant Acetate Injection Market Facts & Figures by Country
3.4.1 North America Icatibant Acetate Injection Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Icatibant Acetate Injection Sales by Country (2021–2032)
3.4.3 North America Icatibant Acetate Injection Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Icatibant Acetate Injection Market Facts & Figures by Country
3.5.1 Europe Icatibant Acetate Injection Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Icatibant Acetate Injection Sales by Country (2021–2032)
3.5.3 Europe Icatibant Acetate Injection Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Icatibant Acetate Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Icatibant Acetate Injection Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Icatibant Acetate Injection Sales by Region (2021–2032)
3.6.3 Asia Pacific Icatibant Acetate Injection Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Icatibant Acetate Injection Market Facts & Figures by Country
3.7.1 Latin America Icatibant Acetate Injection Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Icatibant Acetate Injection Sales by Country (2021–2032)
3.7.3 Latin America Icatibant Acetate Injection Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Icatibant Acetate Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Icatibant Acetate Injection Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Icatibant Acetate Injection Sales by Country (2021–2032)
3.8.3 Middle East and Africa Icatibant Acetate Injection Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Icatibant Acetate Injection Sales by Type (2021–2032)
4.1.1 Global Icatibant Acetate Injection Sales by Type (2021–2026)
4.1.2 Global Icatibant Acetate Injection Sales by Type (2027–2032)
4.1.3 Global Icatibant Acetate Injection Sales Market Share by Type (2021–2032)
4.2 Global Icatibant Acetate Injection Revenue by Type (2021–2032)
4.2.1 Global Icatibant Acetate Injection Revenue by Type (2021–2026)
4.2.2 Global Icatibant Acetate Injection Revenue by Type (2027–2032)
4.2.3 Global Icatibant Acetate Injection Revenue Market Share by Type (2021–2032)
4.3 Global Icatibant Acetate Injection Price by Type (2021–2032)
5 Segment by Application
5.1 Global Icatibant Acetate Injection Sales by Application (2021–2032)
5.1.1 Global Icatibant Acetate Injection Sales by Application (2021–2026)
5.1.2 Global Icatibant Acetate Injection Sales by Application (2027–2032)
5.1.3 Global Icatibant Acetate Injection Sales Market Share by Application (2021–2032)
5.2 Global Icatibant Acetate Injection Revenue by Application (2021–2032)
5.2.1 Global Icatibant Acetate Injection Revenue by Application (2021–2026)
5.2.2 Global Icatibant Acetate Injection Revenue by Application (2027–2032)
5.2.3 Global Icatibant Acetate Injection Revenue Market Share by Application (2021–2032)
5.3 Global Icatibant Acetate Injection Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Takeda Pharmaceuticals
6.1.1 Takeda Pharmaceuticals Company Information
6.1.2 Takeda Pharmaceuticals Description and Business Overview
6.1.3 Takeda Pharmaceuticals Icatibant Acetate Injection Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Takeda Pharmaceuticals Icatibant Acetate Injection Product Portfolio
6.1.5 Takeda Pharmaceuticals Recent Developments/Updates
6.2 Eugia Pharma Specialities
6.2.1 Eugia Pharma Specialities Company Information
6.2.2 Eugia Pharma Specialities Description and Business Overview
6.2.3 Eugia Pharma Specialities Icatibant Acetate Injection Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Eugia Pharma Specialities Icatibant Acetate Injection Product Portfolio
6.2.5 Eugia Pharma Specialities Recent Developments/Updates
6.3 Glenmark Pharmaceuticals
6.3.1 Glenmark Pharmaceuticals Company Information
6.3.2 Glenmark Pharmaceuticals Description and Business Overview
6.3.3 Glenmark Pharmaceuticals Icatibant Acetate Injection Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Glenmark Pharmaceuticals Icatibant Acetate Injection Product Portfolio
6.3.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.4 Sandoz
6.4.1 Sandoz Company Information
6.4.2 Sandoz Description and Business Overview
6.4.3 Sandoz Icatibant Acetate Injection Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Sandoz Icatibant Acetate Injection Product Portfolio
6.4.5 Sandoz Recent Developments/Updates
6.5 Cipla
6.5.1 Cipla Company Information
6.5.2 Cipla Description and Business Overview
6.5.3 Cipla Icatibant Acetate Injection Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Cipla Icatibant Acetate Injection Product Portfolio
6.5.5 Cipla Recent Developments/Updates
6.6 Fresenius Kabi
6.6.1 Fresenius Kabi Company Information
6.6.2 Fresenius Kabi Description and Business Overview
6.6.3 Fresenius Kabi Icatibant Acetate Injection Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Fresenius Kabi Icatibant Acetate Injection Product Portfolio
6.6.5 Fresenius Kabi Recent Developments/Updates
6.7 Jiangsu Hengrui Pharmaceuticals
6.7.1 Jiangsu Hengrui Pharmaceuticals Company Information
6.7.2 Jiangsu Hengrui Pharmaceuticals Description and Business Overview
6.7.3 Jiangsu Hengrui Pharmaceuticals Icatibant Acetate Injection Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Jiangsu Hengrui Pharmaceuticals Icatibant Acetate Injection Product Portfolio
6.7.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
6.8 Chengdu Shengnuo Biology Pharmacy
6.8.1 Chengdu Shengnuo Biology Pharmacy Company Information
6.8.2 Chengdu Shengnuo Biology Pharmacy Description and Business Overview
6.8.3 Chengdu Shengnuo Biology Pharmacy Icatibant Acetate Injection Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Chengdu Shengnuo Biology Pharmacy Icatibant Acetate Injection Product Portfolio
6.8.5 Chengdu Shengnuo Biology Pharmacy Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Icatibant Acetate Injection Industry Chain Analysis
7.2 Icatibant Acetate Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Icatibant Acetate Injection Production Mode & Process Analysis
7.4 Icatibant Acetate Injection Sales and Marketing
7.4.1 Icatibant Acetate Injection Sales Channels
7.4.2 Icatibant Acetate Injection Distributors
7.5 Icatibant Acetate Injection Customer Analysis
8 Icatibant Acetate Injection Market Dynamics
8.1 Icatibant Acetate Injection Industry Trends
8.2 Icatibant Acetate Injection Market Drivers
8.3 Icatibant Acetate Injection Market Challenges
8.4 Icatibant Acetate Injection Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Icatibant Acetate Injection Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Icatibant Acetate Injection Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Icatibant Acetate Injection Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Icatibant Acetate Injection Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Icatibant Acetate Injection Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Icatibant Acetate Injection Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Icatibant Acetate Injection Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Icatibant Acetate Injection Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Icatibant Acetate Injection, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Icatibant Acetate Injection, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Icatibant Acetate Injection, Product Types and Applications
 Table 12. Global Key Manufacturers of Icatibant Acetate Injection, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Icatibant Acetate Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Icatibant Acetate Injection Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Icatibant Acetate Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Icatibant Acetate Injection Sales by Region (K Units), 2021–2026
 Table 18. Global Icatibant Acetate Injection Sales Market Share by Region (2021–2026)
 Table 19. Global Icatibant Acetate Injection Sales by Region (K Units), 2027–2032
 Table 20. Global Icatibant Acetate Injection Sales Market Share by Region (2027–2032)
 Table 21. Global Icatibant Acetate Injection Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Icatibant Acetate Injection Revenue Market Share by Region (2021–2026)
 Table 23. Global Icatibant Acetate Injection Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Icatibant Acetate Injection Revenue Market Share by Region (2027–2032)
 Table 25. North America Icatibant Acetate Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Icatibant Acetate Injection Sales by Country (K Units), 2021–2026
 Table 27. North America Icatibant Acetate Injection Sales by Country (K Units), 2027–2032
 Table 28. North America Icatibant Acetate Injection Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Icatibant Acetate Injection Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Icatibant Acetate Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Icatibant Acetate Injection Sales by Country (K Units), 2021–2026
 Table 32. Europe Icatibant Acetate Injection Sales by Country (K Units), 2027–2032
 Table 33. Europe Icatibant Acetate Injection Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Icatibant Acetate Injection Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Icatibant Acetate Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Icatibant Acetate Injection Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Icatibant Acetate Injection Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Icatibant Acetate Injection Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Icatibant Acetate Injection Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Icatibant Acetate Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Icatibant Acetate Injection Sales by Country (K Units), 2021–2026
 Table 42. Latin America Icatibant Acetate Injection Sales by Country (K Units), 2027–2032
 Table 43. Latin America Icatibant Acetate Injection Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Icatibant Acetate Injection Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Icatibant Acetate Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Icatibant Acetate Injection Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Icatibant Acetate Injection Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Icatibant Acetate Injection Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Icatibant Acetate Injection Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Icatibant Acetate Injection Sales (K Units) by Type (2021–2026)
 Table 51. Global Icatibant Acetate Injection Sales (K Units) by Type (2027–2032)
 Table 52. Global Icatibant Acetate Injection Sales Market Share by Type (2021–2026)
 Table 53. Global Icatibant Acetate Injection Sales Market Share by Type (2027–2032)
 Table 54. Global Icatibant Acetate Injection Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Icatibant Acetate Injection Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Icatibant Acetate Injection Revenue Market Share by Type (2021–2026)
 Table 57. Global Icatibant Acetate Injection Revenue Market Share by Type (2027–2032)
 Table 58. Global Icatibant Acetate Injection Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Icatibant Acetate Injection Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Icatibant Acetate Injection Sales (K Units) by Application (2021–2026)
 Table 61. Global Icatibant Acetate Injection Sales (K Units) by Application (2027–2032)
 Table 62. Global Icatibant Acetate Injection Sales Market Share by Application (2021–2026)
 Table 63. Global Icatibant Acetate Injection Sales Market Share by Application (2027–2032)
 Table 64. Global Icatibant Acetate Injection Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Icatibant Acetate Injection Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Icatibant Acetate Injection Revenue Market Share by Application (2021–2026)
 Table 67. Global Icatibant Acetate Injection Revenue Market Share by Application (2027–2032)
 Table 68. Global Icatibant Acetate Injection Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Icatibant Acetate Injection Price (US$/Unit) by Application (2027–2032)
 Table 70. Takeda Pharmaceuticals Company Information
 Table 71. Takeda Pharmaceuticals Description and Business Overview
 Table 72. Takeda Pharmaceuticals Icatibant Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Takeda Pharmaceuticals Icatibant Acetate Injection Product
 Table 74. Takeda Pharmaceuticals Recent Developments/Updates
 Table 75. Eugia Pharma Specialities Company Information
 Table 76. Eugia Pharma Specialities Description and Business Overview
 Table 77. Eugia Pharma Specialities Icatibant Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Eugia Pharma Specialities Icatibant Acetate Injection Product
 Table 79. Eugia Pharma Specialities Recent Developments/Updates
 Table 80. Glenmark Pharmaceuticals Company Information
 Table 81. Glenmark Pharmaceuticals Description and Business Overview
 Table 82. Glenmark Pharmaceuticals Icatibant Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Glenmark Pharmaceuticals Icatibant Acetate Injection Product
 Table 84. Glenmark Pharmaceuticals Recent Developments/Updates
 Table 85. Sandoz Company Information
 Table 86. Sandoz Description and Business Overview
 Table 87. Sandoz Icatibant Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Sandoz Icatibant Acetate Injection Product
 Table 89. Sandoz Recent Developments/Updates
 Table 90. Cipla Company Information
 Table 91. Cipla Description and Business Overview
 Table 92. Cipla Icatibant Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Cipla Icatibant Acetate Injection Product
 Table 94. Cipla Recent Developments/Updates
 Table 95. Fresenius Kabi Company Information
 Table 96. Fresenius Kabi Description and Business Overview
 Table 97. Fresenius Kabi Icatibant Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Fresenius Kabi Icatibant Acetate Injection Product
 Table 99. Fresenius Kabi Recent Developments/Updates
 Table 100. Jiangsu Hengrui Pharmaceuticals Company Information
 Table 101. Jiangsu Hengrui Pharmaceuticals Description and Business Overview
 Table 102. Jiangsu Hengrui Pharmaceuticals Icatibant Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Jiangsu Hengrui Pharmaceuticals Icatibant Acetate Injection Product
 Table 104. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
 Table 105. Chengdu Shengnuo Biology Pharmacy Company Information
 Table 106. Chengdu Shengnuo Biology Pharmacy Description and Business Overview
 Table 107. Chengdu Shengnuo Biology Pharmacy Icatibant Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Chengdu Shengnuo Biology Pharmacy Icatibant Acetate Injection Product
 Table 109. Chengdu Shengnuo Biology Pharmacy Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Icatibant Acetate Injection Distributors List
 Table 113. Icatibant Acetate Injection Customers List
 Table 114. Icatibant Acetate Injection Market Trends
 Table 115. Icatibant Acetate Injection Market Drivers
 Table 116. Icatibant Acetate Injection Market Challenges
 Table 117. Icatibant Acetate Injection Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Icatibant Acetate Injection
 Figure 2. Global Icatibant Acetate Injection Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Icatibant Acetate Injection Market Share by Type: 2025 & 2032
 Figure 4. Original Drug Product Picture
 Figure 5. Generic Drug Product Picture
 Figure 6. Global Icatibant Acetate Injection Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Icatibant Acetate Injection Market Share by Application: 2025 & 2032
 Figure 8. Hospital and Clinic
 Figure 9. Pharmacy
 Figure 10. Other
 Figure 11. Global Icatibant Acetate Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Icatibant Acetate Injection Market Size (US$ Million), 2021–2032
 Figure 13. Global Icatibant Acetate Injection Sales (K Units), 2021–2032
 Figure 14. Global Icatibant Acetate Injection Average Price (US$/Unit), 2021–2032
 Figure 15. Icatibant Acetate Injection Report Years Considered
 Figure 16. Icatibant Acetate Injection Sales Share by Manufacturers in 2025
 Figure 17. Global Icatibant Acetate Injection Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Icatibant Acetate Injection Players: Market Share by Revenue in Icatibant Acetate Injection in 2025
 Figure 19. Icatibant Acetate Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Icatibant Acetate Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Icatibant Acetate Injection Sales Market Share by Country (2021–2032)
 Figure 22. North America Icatibant Acetate Injection Revenue Market Share by Country (2021–2032)
 Figure 23. United States Icatibant Acetate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Icatibant Acetate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Icatibant Acetate Injection Sales Market Share by Country (2021–2032)
 Figure 26. Europe Icatibant Acetate Injection Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Icatibant Acetate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Icatibant Acetate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Icatibant Acetate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Icatibant Acetate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Icatibant Acetate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Icatibant Acetate Injection Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Icatibant Acetate Injection Revenue Market Share by Region (2021–2032)
 Figure 34. China Icatibant Acetate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Icatibant Acetate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Icatibant Acetate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Icatibant Acetate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Icatibant Acetate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Icatibant Acetate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia Icatibant Acetate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America Icatibant Acetate Injection Sales Market Share by Country (2021–2032)
 Figure 42. Latin America Icatibant Acetate Injection Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico Icatibant Acetate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil Icatibant Acetate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina Icatibant Acetate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia Icatibant Acetate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa Icatibant Acetate Injection Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa Icatibant Acetate Injection Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey Icatibant Acetate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia Icatibant Acetate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE Icatibant Acetate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of Icatibant Acetate Injection by Type (2021–2032)
 Figure 53. Global Revenue Market Share of Icatibant Acetate Injection by Type (2021–2032)
 Figure 54. Global Icatibant Acetate Injection Price (US$/Unit) by Type (2021–2032)
 Figure 55. Global Sales Market Share of Icatibant Acetate Injection by Application (2021–2032)
 Figure 56. Global Revenue Market Share of Icatibant Acetate Injection by Application (2021–2032)
 Figure 57. Global Icatibant Acetate Injection Price (US$/Unit) by Application (2021–2032)
 Figure 58. Icatibant Acetate Injection Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network